Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Erik Procko

19PUBLICATIONS
51CO-AUTHORS
Environmental epidemiologyBiologically active moleculesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyMedical devices
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

Sort by Publication Date:
|Nov 06, 2023
Sequence basis for selectivity of ephrin-B2 ligand for Eph receptors and pathogenic henipavirus G glycoproteins.

Krishna K Narayanan, Moushimi Amaya, Natalie Tsang

|May 12, 2023
A computationally designed ACE2 decoy has broad efficacy against SARS-CoV-2 omicron variants and related viruses in vitro and in vivo.

Brandon Havranek, Graeme Walker Lindsey, Yusuke Higuchi

|Feb 24, 2023
Xeno interactions between MHC-I proteins and molecular chaperones enable ligand exchange on a broad repertoire of HLA allotypes.

Yi Sun, Georgia F Papadaki, Christine A Devlin

|Sep 12, 2022
An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS-CoV-2.

Lianghui Zhang, Krishna K Narayanan, Laura Cooper

|Jun 21, 2022
TAPBPR employs a ligand-independent docking mechanism to chaperone MR1 molecules.

Andrew C McShan, Christine A Devlin, Georgia F Papadaki

|Mar 21, 2022
A tethered ligand assay to probe SARS-CoV-2:ACE2 interactions.

Magnus S Bauer, Sophia Gruber, Adina Hausch

Pageof 4

Frequent Collaborators

4 joint publications

Nikolaos G Sgourakis

4 joint publications

Christine A Devlin

2 joint publications

Jeremiah Dallas Heredia

2 joint publications

Asrar B Malik

2 joint publications

Kevin Sean Gill

2 joint publications

Andrew C McShan

2 joint publications

Jalees Rehman

2 joint publications

George M Burslem

2 joint publications

Laura M Cooper

2 joint publications

Kui K Chan

Frequent Collaborators

4 joint publications

Nikolaos G Sgourakis

4 joint publications

Christine A Devlin

2 joint publications

Jeremiah Dallas Heredia

2 joint publications

Asrar B Malik

Top Related Videos

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

59.0K
Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay
05:49

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Published on : Nov 21, 2023

1.8K
Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on : Feb 28, 2019

9.9K
See more related videos

Top Related Videos

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting
08:40

Production of Pseudotyped Particles to Study Highly Pathogenic Coronaviruses in a Biosafety Level 2 Setting

Published on : Mar 01, 2019

59.0K
Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay
05:49

Pseudotyped Viruses As a Molecular Tool to Monitor Humoral Immune Responses Against SARS-CoV-2 Via Neutralization Assay

Published on : Nov 21, 2023

1.8K
Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
12:09

Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation

Published on : Feb 28, 2019

9.9K
See more related videos